Alberghina C, Torrisi F, D’Aprile S, Longhitano L, Giallongo S, Scandura G, Mannino G, Mele S, Sabini MG, Cammarata FP, Russo G, Abdelhameed AS, Zappalà A, Lo Furno D, Giuffrida R, Li Volti G, Tibullo D, Vicario N, Parenti R. Microglia and glioblastoma heterocellular interplay sustains tumour growth and proliferation as an off-target effect of radiotherapy. Cell Prolif (Publisched on-line: March 7, 2024) Fattizzo B, Vercellati C, Marcello A, Patel P, Wind-Rotolo M, Pettine L, Bonanomi M, Gaglio D, Bortolotti M, Leoni C, Fermo E, Bianchi P, Zaninoni A, Passamonti F, Barcellini W. Glycolytic activity and in vitro effect of the pyruvate kinase activator AG-946 in red blood cells from low-risk myelodysplastic syndromes patients: A proof-of-concept study. Am J Hematol (Published on-line: April 2, 2024)